Clinical Trials Contact Us Careers Home Search FDA Approved Read about our latest treatment now approved in the U.S. Learn More CAREERS AT BIOMARIN Our focus on rare disease gives us the rare opportunity to truly impact lives. Learn More OUR MOTIVATION We are inspired and driven everyday by stories like Sheri’s. Learn More PATIENT & COMMUNITY SUPPORT Treatment is only the beginning. We are committed to the communities we treat beyond the therapies we develop. Learn More OUR PIPELINE We take on the biggest challenges in rare disease. Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. View Now NEWS View All News November 19, 2021 BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates October 27, 2021 BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates October 25, 2021 BioMarin to Participate in Four Upcoming Virtual Investor Conferences October 12, 2021 BioMarin to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Wednesday, October 27 at 4:30pm ET October 4, 2021 BioMarin Hires Industry Veterans to Fill Key Roles in R&D and Technical Operations November 17, 2020 BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence November 12, 2020 BioMarin to Participate in Three Upcoming Virtual Investor Conferences November 9, 2020 BioMarin Expands Vosoritide Clinical Program Home Navigate Our Motivation Our Science Our Treatments Our Company Investors & Media About Our History Our Products Our Pipeline Leadership Team Board of Directors Diversity, Equity & Inclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request Funding & Support Connect Careers LinkedIn Facebook Instagram YouTube Privacy Policy Terms of Use Site Map Supplier Information Slavery Act Statement Glossary Contact Us © 2021 BioMarin. All rights reserved. You may delete or block cookies by accessing your preferences. For more information, please see our Privacy Policy and Terms and Conditions. By using this website, you consent to our use of cookies.Accept